Evidence map›Paper›PMID 36947299›Full record

ArticleInflammopharmacology2023

Liquiritigenin, isoliquiritigenin rich extract of glycyrrhiza glabra roots attenuates inflammation in macrophages and collagen-induced arthritis in rats.

Vineet Babu, Deepak Singh Kapkoti, Monika Binwal, Rajendra S Bhakuni, Karuna Shanker, Manju Singh, Sudeep Tandon, Madhav N Mugale, Narendra Kumar, Dnyaneshwar U Bawankule

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Frontiers in pharmacology · 2024
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Vineet BabuBioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Post Office-CIMAP, Near Kukrail Picnic Spot, Lucknow, Uttar Pradesh, 226015, India.
Deepak Singh KapkotiPhytochemistry Division, Central Institute of Medicinal and Aromatic Plants (CSIR), Lucknow, 226015, India.
Monika BinwalBioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Post Office-CIMAP, Near Kukrail Picnic Spot, Lucknow, Uttar Pradesh, 226015, India.
Rajendra S BhakuniPhytochemistry Division, Central Institute of Medicinal and Aromatic Plants (CSIR), Lucknow, 226015, India. bhakunirs2000@gmail.com.
Karuna ShankerPhytochemistry Division, Analytical Chemistry Lab, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, 226015, India.
Manju SinghPhytochemistry Division, Analytical Chemistry Lab, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, 226015, India.
Sudeep TandonProcess Chemistry and Chemical Engineering Department, Central Institute of Medicinal and Aromatic Plants (CIMAP), Council of Scientific and Industrial Research (CSIR), PO CIMAP, Near Kukrail Picnic Spot, Lucknow, 226015, India.
Madhav N MugaleDepartment of Toxicology & Experimental Medicine, CSIR-Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh, 226031, India.
Narendra KumarBotany and Pharmacognosy, CSIR-Central Institute of Medicinal and Aromatic Plants (CIMAP), Lucknow, Uttar Pradesh, India.
Dnyaneshwar U BawankuleBioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Post Office-CIMAP, Near Kukrail Picnic Spot, Lucknow, Uttar Pradesh, 226015, India. bawankuledu@gmail.com.ORCID http://orcid.org/0000-0003-0677-0981
Central Institute of Medicinal and Aromatic Plants · INCentral Drug Research Institute · INCouncil of Scientific and Industrial Research · IN

Funding

csir-cimap CSIR- Emeritus Scientist project 21(1050)/18 EMR-IIcsir-cimap HCP-010
6 · The paper itself

Abstract

Liquiritigenin (LTG) and its bioprecursor isoliquiritigenin(ISL), the main bioactives from roots of Glycyrrhiza genus are progressively documented as a potential pharmacological agent for the management of chronic diseases. The aim of this study was to evaluate the pharmacological potential of liquiritigenin, isoliquiritigenin rich extract of Glycyrrhiza glabra roots (IVT-21) against the production of pro-inflammatory cytokines from activated macrophages as well as further validated the efficacy in collagen-induced arthritis model in rats. We also performed the safety profile of IVT-21 using standard in-vitro and in-vivo assays. Results of this study revealed that the treatment of IVT-21 and its major bioactives (LTG, ISL) was able to reduce the production of pro-inflammatory cytokines (TNF-α, IL-6) in LPS-activated primary peritoneal macrophages in a dose-dependent manner compared with vehicle-alone treated cells without any cytotoxic effect on macrophages. In-vivo efficacy profile against collagen-induced arthritis in Rats revealed that oral administration of IVT-21 significantly reduced the arthritis index, arthritis score, inflammatory mediators level in serum. IVT-21 oral treatment is also able to reduce the NFкB-p65 expression as evidence of immunohistochemistry in knee joint tissue and mRNA level of pro-inflammatory cytokines in paw tissue in a dose-dependent manner when compared with vehicle treated rats. Acute oral toxicity profile of IVT-21 demonstrated that it is safe up to 2000 mg/kg body weight in experimental mice. This result suggests the suitability of IVT-21 for further study in the management of arthritis and related complications.

Indexed as

Arthritis, ExperimentalGlycyrrhizaAnimalsChalconesCytokinesFlavanonesInflammationMacrophagesMicePlant ExtractsRatsChalconesCytokinesFlavanonesisoliquiritigeninliquiritigeninPlant ExtractsAnti-inflammatory arthritisGlycyrrhiza glabraIsoliquiritigeninLiquiritigeninRoot

Identifiers

PMID36947299
OpenAlexW4353015264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.